Products

The current Takeda Products Ireland Ltd portfolio comprises of the following medicines.

To download a patient information leaflet (PIL) and a summary of product characteristics (SmPC) for each medicine, simply follow the links within the table below.

If you are concerned about any of the conditions or treatments listed below please consult your General Practitioner or other healthcare professional.

Actos® - pioglitazone hydrochloride
Actos 15mg, 30 mg, 45 mg tablets SmPC PIL
Adcetris®  brentuximab vedotin
Adcetris 50 mg powder for concentrate for solution for infusion SmPC PIL
Alofisel® - darvadstrocel *
Alofisel 5 million cells/mL suspension for injection  SmPC PIL
Alunbrig® ▼ - brigatinib
Alunbrig 30 mg, 90 mg, 180 mg film-coated tablets  SmPC PIL
Blopress® - candesartan cilexetil
Blopress tablets 2mg, 4mg, 8mg, 16mg, 32mg. SmPC PIL
Blopress® Plus – hydrochlorothiazide, candesartan cilexetil
Blopress Plus 8 mg/12.5 mg, 16 mg/12.5 mg, 32 mg/12.5 mg, 32 mg/25 mg  SmPC PIL
Calcichew® Portfolio - calcium carbonate +/- cholecalciferol (vitamin D3)
Calcichew 500 mg chewable tablets SmPC PIL
Calcichew D3 Forte chewable tablets SmPC PIL
Calcichew D3 Forte double strength 1000 mg/800 IU chewable tablets SmPC PIL
Competact® - metformin hydrochloride, pioglitazone hydrochloride
Competact 15 mg/850 mg film-coated tablets SmPC PIL
Condyline Cutaneous Solution - podophyllotoxin
Condyline cutaneous solution 0.5 % w/v SmPC PIL
Edarbi® - azilsartan medoxomil potassium
Edarbi 20 mg, 40 mg, 80 mg tablets SmPC PIL
Entyvio® – vedolizumab
Entyvio 300 mg powder for concentrate for solution for infusion SmPC PIL
Instanyl® - fentanyl citrate
Instanyl 50, 100 and 200 mcg nasal spray, solution in single-dose container SmPC PIL
Matrifen® - fentanyl
Matrifen transdermal patch SmPC PIL
Mepact® - mifamurtide
Mepact 4 mg powder for suspension for infusion SmPC PIL
Midon® - midodrine hydrochloride
Midon 2.5 mg tablets SmPC PIL
Midon 5 mg tablets SmPC PIL
Ninlaro® ▼ - ixazomib citrate
Ninlaro 2.3 mg, 3 mg, 4 mg hard capsules SmPC PIL
Prostap® - leuprorelin acetate
Prostap SR DCS SmPC PIL
Prostap 3 DCS SmPC PIL
Prostap 6 DCS SmPC PIL
Protium® - pantoprazole sodium sesquihydrate
Protium 20 mg SmPC PIL
Protium 40 mg SmPC PIL
Protium 40 mg iv SmPC PIL
TachoSil® - 5.5 mg fibrinogen, 2.0 IU thrombin/cm2
Tachosil sealant matrix SmPC PIL

 
*Alofisel is marketed by Takeda Ireland under license from TiGenix

The black triangle denotes that additional monitoring is required in relation to adverse reactions.  This allows quick identification of new safety information.

Adverse Event and Product Complaint Reporting

If you experience any adverse events, talk to your doctor or pharmacist. Adverse Events should be reported to the Pharmacovigilance Unit at the Health Products Regulatory Authority medsafety@hpra.ie. Information about Adverse Event reporting can be found on the HPRA website www.hpra.ie.

Adverse events should also be reported to Takeda Products UK on 1800 937 970 or e-mail DSO-UK@takeda.com

 

 

IRE/WBC/18/0008c(2)

Date of Preparation: April 2019